PortfoliosLab logoPortfoliosLab logo
Kamada (KMDA)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
IL0010941198
CUSIP
M6240T109
IPO Date
May 31, 2013

Highlights

Market Cap
$514.26M
Enterprise Value
$452.46M
EPS (TTM)
$0.34
PE Ratio
24.31
PEG Ratio
7.36
Total Revenue (TTM)
$181.38M
Gross Profit (TTM)
$76.76M
EBITDA (TTM)
$37.96M
Year Range
$5.54 - $9.35
Target Price
$12.00
ROA (TTM)
5.35%
ROE (TTM)
7.53%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Kamada

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Kamada, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Kamada (KMDA) has returned 21.71% so far this year and 30.00% over the past 12 months. Over the last ten years, KMDA has returned 8.73% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Kamada

1D
3.35%
1M
-1.23%
YTD
21.71%
6M
23.81%
1Y
30.00%
3Y*
23.92%
5Y*
7.38%
10Y*
8.73%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since May 31, 2013, KMDA's average daily return is +0.03%, while the average monthly return is +0.53%. At this rate, your investment would double in approximately 10.9 years.

Historically, 49% of months were positive and 51% were negative. The best month was Nov 2019 with a return of +42.1%, while the worst month was May 2014 at -44.0%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.

On a daily basis, KMDA closed higher 46% of trading days. The best single day was Dec 6, 2023 with a return of +20.9%, while the worst single day was May 16, 2014 at -34.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202617.85%4.57%-1.23%21.71%
202510.51%2.38%-1.31%-2.12%5.87%13.14%-4.65%-6.36%0.29%-0.29%-3.18%5.37%19.25%
2024-6.37%9.95%-10.95%-6.95%0.96%-5.88%13.91%1.77%-6.61%6.89%2.61%3.40%-0.49%
202316.71%-7.69%7.52%0.32%3.65%9.21%-6.54%16.63%-7.13%-20.79%11.82%29.39%52.62%
2022-8.05%-8.26%-0.54%-2.72%-16.01%-0.00%13.75%-2.73%-9.62%-0.00%4.21%-14.68%-39.06%
2021-0.15%-5.10%0.81%-2.58%-2.65%-0.85%-6.53%-1.10%-1.49%7.74%9.11%5.62%1.54%

Benchmark Metrics

Kamada has an annualized alpha of 0.92%, beta of 0.56, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since June 03, 2013.

  • This stock participated in 93.10% of S&P 500 Index downside but only 43.61% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.56 may look defensive, but with R² of 0.05 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
0.92%
Beta
0.56
0.05
Upside Capture
43.61%
Downside Capture
93.10%

Return for Risk

Risk / Return Rank

KMDA ranks 66 for risk / return — better than 66% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


KMDA Risk / Return Rank: 6666
Overall Rank
KMDA Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
KMDA Sortino Ratio Rank: 6666
Sortino Ratio Rank
KMDA Omega Ratio Rank: 6161
Omega Ratio Rank
KMDA Calmar Ratio Rank: 7171
Calmar Ratio Rank
KMDA Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Kamada (KMDA) and compare them to a chosen benchmark (S&P 500 Index).


KMDABenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.85

0.90

-0.04

Sortino ratio

Return per unit of downside risk

1.45

1.39

+0.07

Omega ratio

Gain probability vs. loss probability

1.17

1.21

-0.04

Calmar ratio

Return relative to maximum drawdown

1.54

1.40

+0.14

Martin ratio

Return relative to average drawdown

2.89

6.61

-3.71

Explore KMDA risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Kamada provided a 3.00% dividend yield over the last twelve months, with an annual payout of $0.25 per share.


2.83%$0.00$0.05$0.10$0.15$0.202025
Dividends
Dividend Yield
PeriodTTM2025
Dividend$0.25$0.20

Dividend yield

3.00%2.83%

Monthly Dividends

The table displays the monthly dividend distributions for Kamada. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.25$0.25
2025$0.20$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.20

Dividend Yield & Payout


Dividend Yield

Kamada has a dividend yield of 3.00%, which is quite average when compared to the overall market.

Payout Ratio

Kamada has a payout ratio of 55.71%, which is quite average when compared to the overall market. This suggests that Kamada strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Kamada. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Kamada was 82.46%, occurring on Nov 25, 2014. The portfolio has not yet recovered.

The current Kamada drawdown is 49.49%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.46%Mar 6, 2014185Nov 25, 2014
-16.52%Oct 15, 201312Oct 30, 201354Jan 17, 201466
-12.82%Jan 23, 20146Jan 30, 201419Feb 27, 201425
-8.3%Aug 7, 201315Aug 27, 201310Sep 11, 201325
-6.83%Jun 4, 20133Jun 6, 20134Jun 12, 20137

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Kamada over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Kamada is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for KMDA, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/E ratio of 24.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for KMDA compared to other companies in the Drug Manufacturers - Specialty & Generic industry. KMDA currently has a PEG ratio of 7.4. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for KMDA relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/S ratio of 2.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for KMDA in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/B value of 1.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items